Profacgen, a leading biotech company in supplying custom protein services, is pleased to release Destabilization Domains Service, opening up new avenues for various applications such as cancer therapy and targeted gene delivery. Designing small-molecule ligands for a protein can be challenging and time-consuming as the process usually involves multiple rounds of screening and structural modification. […]
